Shopping Cart
- Remove All
- Your shopping cart is currently empty
KLS-13019 is a Cannabidiol-Derived Neuroprotective Agent with Improved Potency, Safety, and Permeability. (EC50=40nM; T1=7500). KLS-13019 was 50-fold more potent and >400-fold safer than cannabidiol and exhibited an in vitro profile consistent with improved oral bioavailability. KLS-13019 was only toxic at 300 μM giving it a therapeutic index of 7500.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $2,258 | 6-8 weeks | |
50 mg | $2,900 | 6-8 weeks | |
100 mg | $3,700 | 6-8 weeks |
Description | KLS-13019 is a Cannabidiol-Derived Neuroprotective Agent with Improved Potency, Safety, and Permeability. (EC50=40nM; T1=7500). KLS-13019 was 50-fold more potent and >400-fold safer than cannabidiol and exhibited an in vitro profile consistent with imp |
Molecular Weight | 355.47 |
Formula | C22H29NO3 |
Cas No. | 1801243-39-9 |
Relative Density. | 1.159 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.